Literature DB >> 8553794

Cervical dystonia (spasmodic torticollis). Some aspects of the natural history.

M Van Zandijcke1.   

Abstract

A literature survey was done to outline the natural history of cervical dystonia (spasmodic torticollis). The disorder starts between 25 and 60 years with head deviation or neck pain. Sometimes, there are personal or familial extrapyramidal antecedents (tremor, dystonia). The role of a preceding neck or head trauma is unsettled. Often, there is a delay in diagnosis of more than one year. The majority of patients show steady progression of their focal dystonia and reach maximal disability after five years; neck pain occurring in 70-80% contributes significantly to disability. In a third of the cases, there is a progression to segmental dystonia. In about 20% of the patients a spontaneous, sustained or unsustained remission of the torticollis can be observed; this occurs particularly in cases with earlier age of onset. Cervical dystonia has important psychosocial consequences: many patients have to withdraw from their job or from social activities.

Entities:  

Mesh:

Year:  1995        PMID: 8553794

Source DB:  PubMed          Journal:  Acta Neurol Belg        ISSN: 0300-9009            Impact factor:   2.396


  10 in total

1.  Health related quality of life is improved by botulinum neurotoxin type A in long term treated patients with focal dystonia.

Authors:  R Hilker; M Schischniaschvili; M Ghaemi; A Jacobs; J Rudolf
Journal:  J Neurol Neurosurg Psychiatry       Date:  2001-08       Impact factor: 10.154

2.  Severity and impact of xerostomia in patients treated with botulinum toxin type b for cervical dystonia: Observations on the quality of life of patients with xerostomia.

Authors:  Patrick Hogan; P David Charles; Maureen Wooten Watts; Janice M Massey; Tamara Miller; John Mackowiack
Journal:  Curr Ther Res Clin Exp       Date:  2004-03

3.  A botulinum toxin A treatment algorithm for de novo management of torticollis and laterocollis.

Authors:  Harald Hefter; Andreas Kupsch; Martina Müngersdorf; Sebastian Paus; Andrea Stenner; Wolfgang Jost
Journal:  BMJ Open       Date:  2011-01-01       Impact factor: 2.692

4.  Factors affecting the health-related quality of life of patients with cervical dystonia and impact of treatment with abobotulinumtoxinA (Dysport): results from a randomised, double-blind, placebo-controlled study.

Authors:  Margaret Mordin; Catherine Masaquel; Chandra Abbott; Catherine Copley-Merriman
Journal:  BMJ Open       Date:  2014-10-16       Impact factor: 2.692

5.  A retrospective study to assess resource utilization in patients with cervical dystonia in the United Kingdom.

Authors:  Mireia Raluy-Callado; Sylvie Gabriel; Jérôme Dinet; Meng Wang; Radek Wasiak
Journal:  Neuropsychiatr Dis Treat       Date:  2015-03-09       Impact factor: 2.570

6.  Disease Progression of Idiopathic Cervical Dystonia in Spite of Improvement After Botulinum Toxin Therapy.

Authors:  Harald Hefter; Isabelle Schomaecker; Max Schomaecker; Sara Samadzadeh
Journal:  Front Neurol       Date:  2020-11-12       Impact factor: 4.003

7.  Isolated Cervical Dystonia: Management and Barriers to Care.

Authors:  Melanie Leigh Supnet; Patrick Acuna; Samuel J Carr; Jan Kristoper de Guzman; Xena Al Qahtani; Trisha Multhaupt-Buell; Taylor Francoeur; Gabrielle E Aldykiewicz; Priyanka R Alluri; Lindsey Campion; Lisa Paul; Laurie Ozelius; Ellen B Penney; Christopher D Stephen; Marisela Dy-Hollins; Nutan Sharma
Journal:  Front Neurol       Date:  2020-11-27       Impact factor: 4.003

8.  Tension-type headache and low back pain reconsidered.

Authors:  Jens Astrup; Finn Gyntelberg
Journal:  Front Neurol       Date:  2022-07-29       Impact factor: 4.086

9.  An open-label cohort study of the improvement of quality of life and pain in de novo cervical dystonia patients after injections with 500 U botulinum toxin A (Dysport).

Authors:  H Hefter; R Benecke; F Erbguth; W Jost; G Reichel; J Wissel
Journal:  BMJ Open       Date:  2013-04-18       Impact factor: 2.692

10.  The Impact of the Course of Disease before Botulinum Toxin Therapy on the Course of Treatment and Long-Term Outcome in Cervical Dystonia.

Authors:  Harald Hefter; Isabelle Schomaecker; Max Schomaecker; Dietmar Rosenthal; Sara Samadzadeh
Journal:  Toxins (Basel)       Date:  2021-07-16       Impact factor: 4.546

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.